TherapeuticsMD (TXMD) Enterprise Value (2010 - 2026)
TherapeuticsMD (TXMD) posted Enterprise Value of -$8.4 million for Q1 2026, down 12.51% on a QoQ basis from -$7.5 million in Q4 2025, and down 46.54% year-over-year from -$15.7 million in Q1 2025.
TherapeuticsMD (TXMD) Enterprise Value (2010 - 2026) Analysis & Trends
TherapeuticsMD's Enterprise Value history runs 17 years deep, the most recent figure standing at -$8.4 million for Q1 2026.
- Quarterly Enterprise Value fell 46.54% year-over-year to -$8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.4 million (down 46.54% YoY) and the FY2025 annual result came in at -$7.5 million, down 47.91% from the prior year.
- Enterprise Value was -$8.4 million for Q1 2026 at TherapeuticsMD, down from -$7.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.3 million in Q4 2023 and bottomed at -$60.6 million in Q4 2022.
- A 5-year average of -$17.0 million and a median of -$7.5 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value soared 92.86% — and 2025, when it plunged 47.91%.
- TherapeuticsMD's Enterprise Value stood at -$60.6 million in 2022, then surged by 92.86% to -$4.3 million in 2023, then dropped by 16.92% to -$5.1 million in 2024, then plunged by 47.91% to -$7.5 million in 2025, then declined by 12.51% to -$8.4 million in 2026.
- Business Quant data shows TXMD's Enterprise Value at -$8.4 million in Q1 2026, -$7.5 million in Q4 2025, and -$7.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | -8.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.42 Mn |
| Dec 31, 2025 | -7.48 Mn |
| Sep 30, 2025 | -7.12 Mn |
| Jun 30, 2025 | -6.07 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Dec 31, 2024 | -5.06 Mn |
| Sep 30, 2024 | -5.05 Mn |
| Jun 30, 2024 | -5.23 Mn |
| Mar 31, 2024 | -4.34 Mn |
| Dec 31, 2023 | -4.33 Mn |
| Sep 30, 2023 | -10.17 Mn |
| Jun 30, 2023 | -13.73 Mn |
| Mar 31, 2023 | -17.25 Mn |
| Dec 31, 2022 | -60.57 Mn |
| Sep 30, 2022 | -49.58 Mn |
| Jun 30, 2022 | -48.80 Mn |
| Mar 31, 2022 | -30.38 Mn |
| Dec 31, 2021 | -64.91 Mn |
| Sep 30, 2021 | -104.84 Mn |
| Jun 30, 2021 | -111.42 Mn |